Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Banks mandated for U.S. listing of German chemicals group Atotech - sources

Published 13/11/2018, 14:48
Updated 13/11/2018, 14:50
© Reuters. The logo of The Carlyle Group is displayed at the company's office in Tokyo

By Arno Schuetze and Joshua Franklin

FRANKFURT/NEW YORK (Reuters) - Buyout group Carlyle (O:CG) has picked four banks to lead the U.S. stock market listing of German speciality chemicals group Atotech, a former part of oil group Total (PA:TOTF), people close to the matter said.

Bank of America (N:BAC), Citi (N:C), Credit Suisse (S:CSGN), JP Morgan (N:JPM) have been chosen to organise the initial public offering, which is expected to take place as early as the second quarter of 2019, the people said.

Carlyle and the banks declined to comment.

Atotech, a Berlin-based maker of speciality chemicals and equipment for printed circuit boards and semiconductors, posted adjusted earnings before interest, tax, depreciation and amortisation (EBITDA) of $329 million on sales of $1.2 billion last year.

Carlyle bought Atotech in 2016 at an enterprise value of $3.2 billion or 12 times its core earnings.

While an offer size has not been decided yet, a share issue of about $600 million has been discussed in initial meetings with banks, one of the sources said.

The company could be valued at around $5 billion, or 13 to 14 times Atotech's expected core profit of up to $400 million, people said earlier this year.

The valuations of U.S.-listed peers such as Cabot Microelectronics (O:CCMP), Entegris (O:ENTG), Quaker Chemical (N:KWR) and Versum Materials (N:VSM) have, however, come down recently and they now trade at only 8.5 to 10 times their expected core earnings.

That is putting pressure on Atotech's potential valuation, which may as a result end up lower, the people said.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

While a listing in New York is seen as the most likely exit route, Carlyle will also consider potential bids from chemicals groups or other investors, people close to the matter have said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.